HomeAI · summaries
Storia in 14 fonti
First vaccine for Bundibugyo Ebola hits human trials in Oxford study
Oxford's Ebola vaccine candidate has entered Phase 1 clinical trials for safety evaluation. The ChAdOx1 BDBV vaccine uses a platform similar to the Covid-19 vaccine. Serum Institute of India manufactured approximately 620,000 doses for potential future use. This initiative builds on a strategic partnership with CEPI and the University of Oxford. Late-stage trials will follow if Phase 1 results prove successful.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
dailymail.com
Britons will be injected with EBOLA 'within weeks' in vaccine trial
Scientists from the University of Oxford will begin injecting 50 adults in the UK with Ebola 'within weeks' in a bid to build immunity against the deadly virus.
- ·
mirror.co.uk
Ebola vaccine breakthrough as Oxford launches first jab against outbreak
Oxford University scientists have rapidly created and launched a UK trial of Ebola jab using same technology as its AstraZeneca vaccine against Covid-19
